EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe

Impact · against what's priced in

The launch of the EXIT-CVD project is a modest positive for Philips, providing a structured pipeline for cardiovascular hardware and software adoption across 17 European countries. While the research scale is significant, the immediate financial impact is limited by the project's long-term (five-year) horizon and the shared nature of the EUR 27.6 million budget.

PHG+0.20

No priced-in read yet